Gainplan LLC Amarin Corp Plcuk Transaction History

Gainplan LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$13.89 - $23.16 $416,700 - $694,800	-30,000 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$16.27 - $20.51 $488,100 - $615,300	30,000 New	30,000 $582,000
Q1 2019 May 13, 2019	SELL	$12.61 - $22.33 $252,200 - $446,599	-20,000 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$12.41 - $22.98 $248,200 - $459,600	20,000 New	20,000 $272,000

183

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $298M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

Stay updated on Gainplan LLC with notifications on news.